SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'STI'

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FMO_E_ADNE351_1 (CAMP-DEPENDENT PROTEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 VAL A 654 ASN A 797 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) None STI  A   3 (-4.4A)	0.66A	1fmoE-1t46A: 21.4	1fmoE-1t46A: 24.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_A_STIA201_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.72A	1iepA-1t46A: 34.7	1iepA-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_B_STIB202_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-3.9A)	0.72A	1iepB-1t46A: 34.7	1iepB-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_B_STIB202_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	VAL A 643 VAL A 654 ARG A 791 LEU A 799	None STI  A   3 (-4.3A) None STI  A   3 (-4.4A)	0.65A	1iepB-1t46A: 34.4	1iepB-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1M17_A_AQ4A999_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.68A	1m17A-1t46A: 26.4	1m17A-1t46A: 31.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MUO_A_ADNA1_1 (AURORA-RELATED KINASE 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 9	LEU A 595 GLY A 596 VAL A 603 ALA A 621 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.76A	1muoA-1t46A: 7.7	1muoA-1t46A: 27.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_A_STIA3_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.55A	1opjA-1t46A: 34.0	1opjA-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_B_STIB4_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 GLY A 676 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-3.9A)	0.55A	1opjB-1t46A: 34.0	1opjB-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_B_STIB4_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	LEU A 595 LYS A 623 VAL A 643 ARG A 791	STI  A   3 ( 3.8A) STI  A   3 (-3.7A) None None	0.79A	1opjB-1t46A: 34.0	1opjB-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 LEU A 644 THR A 670 CYH A 673 LEU A 783 HIS A 790	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) None STI  A   3 (-4.5A)	0.57A	1uwhA-1t46A: 19.3	1uwhA-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWH_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	VAL A 603 VAL A 643 ILE A 653 ASP A 810	STI  A   3 ( 4.6A) None None STI  A   3 (-3.9A)	0.69A	1uwhA-1t46A: 19.3	1uwhA-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	ALA A 621 LYS A 623 GLU A 640 LEU A 644 THR A 670 CYH A 673 LEU A 783 HIS A 790	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) None STI  A   3 (-4.5A)	0.59A	1uwhB-1t46A: 18.9	1uwhB-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWH_B_BAXB1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	VAL A 603 VAL A 643 ILE A 653 ASP A 810	STI  A   3 ( 4.6A) None None STI  A   3 (-3.9A)	0.69A	1uwhB-1t46A: 18.9	1uwhB-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 CYH A 673 LEU A 783 HIS A 790	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) None STI  A   3 (-4.5A)	0.66A	1uwjA-1t46A: 28.2	1uwjA-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	LYS A 623 LEU A 644 ILE A 653 ASP A 810	STI  A   3 (-3.7A) STI  A   3 (-4.4A) None STI  A   3 (-3.9A)	0.55A	1uwjA-1t46A: 28.2	1uwjA-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 CYH A 673 LEU A 783 HIS A 790	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) None STI  A   3 (-4.5A)	0.65A	1uwjB-1t46A: 28.4	1uwjB-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1UWJ_B_BAXB1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	3 / 3	ILE A 798 ASP A 810 PHE A 811	None STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.57A	1uwjB-1t46A: 28.4	1uwjB-1t46A: 30.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 THR A 670 GLY A 676 LEU A 679 ARG A 683 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) None None STI  A   3 (-4.4A)	0.63A	1xkkA-1t46A: 24.4	1xkkA-1t46A: 31.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EUF_B_LQQB401_1 (CELL DIVISION PROTEIN KINASE 6)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	VAL A 603 LYS A 623 VAL A 654 ASP A 677 ASN A 797 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 (-4.3A) None None STI  A   3 (-4.4A)	0.61A	2eufB-1t46A: 18.8	2eufB-1t46A: 26.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 TYR A 672 ASN A 797	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 ( 4.0A) None	0.50A	2fumC-1t46A: 17.7	2fumC-1t46A: 27.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2GQG_B_1N1B502_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.70A	2gqgB-1t46A: 31.6	2gqgB-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_A_STIA600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.63A	2hyyA-1t46A: 34.4	2hyyA-1t46A: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_A_STIA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	LEU A 595 LYS A 623 VAL A 643 ARG A 791	STI  A   3 ( 3.8A) STI  A   3 (-3.7A) None None	1.01A	2hyyA-1t46A: 34.4	2hyyA-1t46A: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_A_STIA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	LEU A 595 VAL A 643 VAL A 654 ARG A 791	STI  A   3 ( 3.8A) None STI  A   3 (-4.3A) None	0.61A	2hyyA-1t46A: 34.4	2hyyA-1t46A: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_B_STIB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.61A	2hyyB-1t46A: 34.9	2hyyB-1t46A: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_C_STIC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.55A	2hyyC-1t46A: 29.4	2hyyC-1t46A: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_D_STID600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.64A	2hyyD-1t46A: 34.8	2hyyD-1t46A: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITO_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.74A	2itoA-1t46A: 24.9	2itoA-1t46A: 31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITY_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 LYS A 623 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.83A	2ityA-1t46A: 26.6	2ityA-1t46A: 31.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITZ_A_IREA2021_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.71A	2itzA-1t46A: 30.8	2itzA-1t46A: 31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2IVU_A_ZD6A3015_0 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 GLY A 596 VAL A 603 LYS A 623 GLU A 640 LEU A 644 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.60A	2ivuA-1t46A: 33.2	2ivuA-1t46A: 45.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.64A	2oiqA-1t46A: 26.2	2oiqA-1t46A: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-3.9A)	0.82A	2oiqA-1t46A: 26.2	2oiqA-1t46A: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 5	LEU A 595 VAL A 643 LEU A 647 ARG A 791	STI  A   3 ( 3.8A) None None None	0.96A	2oiqA-1t46A: 26.2	2oiqA-1t46A: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PL0_A_STIA200_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.72A	2pl0A-1t46A: 25.2	2pl0A-1t46A: 36.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PL0_A_STIA200_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-3.9A)	0.81A	2pl0A-1t46A: 25.2	2pl0A-1t46A: 36.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Y6O_A_1N1A1892_1 (EPHRIN TYPE-A RECEPTOR 4)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.52A	2y6oA-1t46A: 33.0	2y6oA-1t46A: 33.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2YFX_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 8	LEU A 595 ALA A 621 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.59A	2yfxA-1t46A: 25.3	2yfxA-1t46A: 36.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ZVA_A_1N1A513_1 (TYROSINE-PROTEIN KINASE LYN)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 VAL A 654 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.85A	2zvaA-1t46A: 24.8	2zvaA-1t46A: 37.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	VAL A 603 ALA A 621 LEU A 656 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) None STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.66A	3bbtB-1t46A: 25.7	3bbtB-1t46A: 29.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3C7Q_A_XINA1172_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	LEU A 595 GLY A 596 GLU A 605 ALA A 621 LYS A 623 VAL A 654 CYH A 673 GLY A 676 LEU A 799 CYH A 809	STI  A   3 ( 3.8A) None None STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-4.5A)	0.79A	3c7qA-1t46A: 30.7	3c7qA-1t46A: 53.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_A_NILA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 VAL A 643 THR A 670 GLY A 676 HIS A 790 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A) STI  A   3 (-4.4A)	0.50A	3cs9A-1t46A: 34.7	3cs9A-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 GLY A 676 HIS A 790 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	1.01A	3cs9B-1t46A: 32.3	3cs9B-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 VAL A 643 THR A 670 GLY A 676 HIS A 790 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.50A	3cs9B-1t46A: 32.3	3cs9B-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 VAL A 643 THR A 670 HIS A 790 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.47A	3cs9C-1t46A: 26.9	3cs9C-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 VAL A 643 THR A 670 GLY A 676 HIS A 790	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A)	0.49A	3cs9D-1t46A: 33.1	3cs9D-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	LEU A 595 VAL A 603 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.78A	3cs9D-1t46A: 33.1	3cs9D-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	LEU A 595 VAL A 603 LYS A 623 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 (-3.9A)	0.88A	3cs9D-1t46A: 33.1	3cs9D-1t46A: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FUP_B_MI1B1_1 (TYROSINE-PROTEIN KINASE JAK2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 LYS A 623 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.47A	3fupB-1t46A: 23.8	3fupB-1t46A: 34.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3FUP_B_MI1B1_1 (TYROSINE-PROTEIN KINASE JAK2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 VAL A 654 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.41A	3fupB-1t46A: 23.8	3fupB-1t46A: 34.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0E_A_B49A9000_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 11	LEU A 595 VAL A 603 ALA A 621 VAL A 654 THR A 670 TYR A 672 CYH A 673 GLY A 676 LEU A 799 CYH A 809	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-4.5A)	0.69A	3g0eA-1t46A: 41.4	3g0eA-1t46A: 93.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0F_A_B49A9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	11 / 11	LEU A 595 VAL A 603 ALA A 621 THR A 670 TYR A 672 CYH A 673 GLY A 676 ASP A 677 LEU A 799 CYH A 809 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) None STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 (-3.6A)	0.76A	3g0fA-1t46A: 41.9	3g0fA-1t46A: 92.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0F_B_B49B9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 10	LEU A 595 VAL A 603 ALA A 621 THR A 670 TYR A 672 CYH A 673 GLY A 676 LEU A 799 CYH A 809 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 (-3.6A)	0.63A	3g0fB-1t46A: 41.6	3g0fB-1t46A: 92.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_A_1N1A1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.64A	3g5dA-1t46A: 30.9	3g5dA-1t46A: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_A_1N1A1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.71A	3g5dA-1t46A: 30.9	3g5dA-1t46A: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_B_1N1B1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.82A	3g5dB-1t46A: 31.0	3g5dB-1t46A: 35.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	ALA A 621 LEU A 644 THR A 670 HIS A 790 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.78A	3gcsA-1t46A: 19.5	3gcsA-1t46A: 25.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LEU A 647 LEU A 644 THR A 670	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) None STI  A   3 (-4.4A) STI  A   3 (-3.2A)	0.98A	3gcsA-1t46A: 19.5	3gcsA-1t46A: 25.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 GLU A 640 LEU A 644 THR A 670 HIS A 790 ASP A 810 PHE A 811	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.73A	3gp0A-1t46A: 16.2	3gp0A-1t46A: 25.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GVU_A_STIA1001_1 (TYROSINE-PROTEIN KINASE ABL2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.58A	3gvuA-1t46A: 28.7	3gvuA-1t46A: 35.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	ALA A 621 LEU A 644 THR A 670 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.60A	3hecA-1t46A: 20.3	3hecA-1t46A: 26.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 LYS A 623 GLU A 640 LEU A 644 THR A 670 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-3.6A)	0.67A	3hecA-1t46A: 20.3	3hecA-1t46A: 26.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 LEU A 644 THR A 670	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A) STI  A   3 (-3.2A)	0.60A	3hegA-1t46A: 20.3	3hegA-1t46A: 26.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK3_A_0LIA1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 HIS A 790 LEU A 799 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.82A	3ik3A-1t46A: 28.5	3ik3A-1t46A: 35.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK3_A_0LIA1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 VAL A 654 HIS A 790 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.46A	3ik3A-1t46A: 28.5	3ik3A-1t46A: 35.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK3_A_0LIA1_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	LEU A 595 LYS A 623 VAL A 643 ARG A 791	STI  A   3 ( 3.8A) STI  A   3 (-3.7A) None None	1.08A	3ik3A-1t46A: 28.5	3ik3A-1t46A: 35.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK3_B_0LIB2_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 HIS A 790 LEU A 799 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.84A	3ik3B-1t46A: 29.2	3ik3B-1t46A: 35.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK3_B_0LIB2_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 VAL A 654 HIS A 790 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.48A	3ik3B-1t46A: 29.2	3ik3B-1t46A: 35.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK3_B_0LIB2_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	LEU A 595 LYS A 623 VAL A 643 ARG A 791	STI  A   3 ( 3.8A) STI  A   3 (-3.7A) None None	1.09A	3ik3B-1t46A: 29.2	3ik3B-1t46A: 35.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K54_A_1N1A1_1 (TYROSINE-PROTEIN KINASE BTK)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.82A	3k54A-1t46A: 30.5	3k54A-1t46A: 34.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_A_STIA2_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.54A	3k5vA-1t46A: 34.0	3k5vA-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_B_STIB2_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.54A	3k5vB-1t46A: 28.4	3k5vB-1t46A: 36.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 8	ALA A 621 LYS A 623 GLU A 640 THR A 670	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A)	0.40A	3lfaA-1t46A: 9.0	3lfaA-1t46A: 26.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LXK_A_MI1A1125_1 (TYROSINE-PROTEIN KINASE JAK3)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 LYS A 623 VAL A 654 TYR A 672	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.3A) STI  A   3 ( 4.0A)	0.61A	3lxkA-1t46A: 16.5	3lxkA-1t46A: 33.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LXK_A_MI1A1125_1 (TYROSINE-PROTEIN KINASE JAK3)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 VAL A 654 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.62A	3lxkA-1t46A: 16.5	3lxkA-1t46A: 33.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LXN_A_MI1A1_1 (NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 GLY A 596 VAL A 603 ALA A 621 LYS A 623 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.49A	3lxnA-1t46A: 22.8	3lxnA-1t46A: 33.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.64A	3ms9A-1t46A: 33.8	3ms9A-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.66A	3ms9B-1t46A: 34.4	3ms9B-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_A_STIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.66A	3mssA-1t46A: 34.0	3mssA-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-3.9A)	0.68A	3mssB-1t46A: 34.0	3mssB-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.58A	3mssB-1t46A: 34.0	3mssB-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_C_STIC1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.69A	3mssC-1t46A: 33.9	3mssC-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.65A	3mssD-1t46A: 34.1	3mssD-1t46A: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.70A	3octA-1t46A: 30.2	3octA-1t46A: 34.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.46A	3oezA-1t46A: 31.9	3oezA-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 VAL A 654 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.67A	3oezA-1t46A: 31.9	3oezA-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 VAL A 643 THR A 670 TYR A 672 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.56A	3oezB-1t46A: 31.9	3oezB-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 LYS A 623 VAL A 643 THR A 670 TYR A 672 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) None STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.81A	3oezB-1t46A: 31.9	3oezB-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 LEU A 644 THR A 670	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A) STI  A   3 (-3.2A)	0.74A	3og7A-1t46A: 26.9	3og7A-1t46A: 30.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 THR A 670 CYH A 673	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 (-4.5A)	0.35A	3og7A-1t46A: 26.9	3og7A-1t46A: 30.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OHT_A_1N1A1000_1 (P38A)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	GLY A 596 VAL A 603 ALA A 621 LYS A 623 LEU A 644 THR A 670	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A) STI  A   3 (-3.2A)	0.59A	3ohtA-1t46A: 16.2	3ohtA-1t46A: 25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OHT_A_1N1A1000_1 (P38A)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	GLY A 596 VAL A 603 ALA A 621 LYS A 623 THR A 670 LEU A 799	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 (-4.4A)	1.07A	3ohtA-1t46A: 16.2	3ohtA-1t46A: 25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OHT_B_1N1B1000_1 (P38A)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	GLY A 596 VAL A 603 ALA A 621 LYS A 623 LEU A 644 THR A 670 GLY A 676	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A)	0.70A	3ohtB-1t46A: 16.2	3ohtB-1t46A: 25.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXZ_A_0LIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 GLY A 676 HIS A 790 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.87A	3oxzA-1t46A: 33.1	3oxzA-1t46A: 36.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXZ_A_0LIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 VAL A 654 THR A 670 GLY A 676 HIS A 790 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.35A	3oxzA-1t46A: 33.1	3oxzA-1t46A: 36.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXZ_A_0LIA1_2 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 9	LEU A 595 LYS A 623 VAL A 643 ARG A 791 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.7A) None None STI  A   3 (-4.4A)	0.89A	3oxzA-1t46A: 33.1	3oxzA-1t46A: 36.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_A_STIA3_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 THR A 670 GLY A 676 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.47A	3pyyA-1t46A: 34.5	3pyyA-1t46A: 35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_B_STIB4_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.57A	3pyyB-1t46A: 32.5	3pyyB-1t46A: 35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_A_1N1A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.87A	3qlgA-1t46A: 31.5	3qlgA-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_A_1N1A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.85A	3qlgA-1t46A: 31.5	3qlgA-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_B_1N1B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.83A	3qlgB-1t46A: 30.9	3qlgB-1t46A: 35.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 LEU A 644 TYR A 672 LEU A 783 HIS A 790	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 ( 4.0A) None STI  A   3 (-4.5A)	0.85A	3rgfA-1t46A: 8.3	3rgfA-1t46A: 25.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_2 (CYCLIN-DEPENDENT KINASE 8)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	LEU A 799 VAL A 654 LEU A 647 ASP A 810	STI  A   3 (-4.4A) STI  A   3 (-4.3A) None STI  A   3 (-3.9A)	0.64A	3rgfA-1t46A: 8.3	3rgfA-1t46A: 25.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_A_1N1A1_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.56A	3sxrA-1t46A: 30.0	3sxrA-1t46A: 35.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_B_1N1B2_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.55A	3sxrB-1t46A: 29.7	3sxrB-1t46A: 35.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UE4_B_DB8B601_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 VAL A 654 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.75A	3ue4B-1t46A: 32.8	3ue4B-1t46A: 36.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZD_A_LEVA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 LEU A 644 CYH A 673 GLY A 676 CYH A 809	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.5A)	0.51A	3wzdA-1t46A: 35.2	3wzdA-1t46A: 53.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZE_A_BAXA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 LEU A 644 GLY A 676 LEU A 783 HIS A 790	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 ( 3.8A) None STI  A   3 (-4.5A)	0.53A	3wzeA-1t46A: 43.5	3wzeA-1t46A: 53.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 8	VAL A 654 CYH A 673 LEU A 799 ILE A 808 CYH A 809 ASP A 810 PHE A 811	STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) None STI  A   3 (-4.5A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.41A	3wzeA-1t46A: 43.5	3wzeA-1t46A: 53.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 THR A 670 LEU A 783 HIS A 790 LEU A 799 ASP A 810 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) None STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.61A	3zosA-1t46A: 34.3	3zosA-1t46A: 32.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	LEU A 595 ALA A 621 LYS A 623 THR A 670 LEU A 783 HIS A 790 ARG A 791 LEU A 799 ASP A 810 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) None STI  A   3 (-4.5A) None STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.72A	3zosA-1t46A: 34.3	3zosA-1t46A: 32.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	ALA A 621 LYS A 623 GLU A 640 THR A 670 LEU A 783 HIS A 790 LEU A 799 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) None STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.61A	3zosB-1t46A: 34.9	3zosB-1t46A: 32.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	ALA A 621 LYS A 623 THR A 670 LEU A 783 HIS A 790 ARG A 791 LEU A 799 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) None STI  A   3 (-4.5A) None STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.75A	3zosB-1t46A: 34.9	3zosB-1t46A: 32.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AG8_A_AXIA2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 VAL A 654 GLY A 676 LEU A 799 CYH A 809 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 (-3.6A)	0.50A	4ag8A-1t46A: 35.1	4ag8A-1t46A: 53.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AGC_A_AXIA2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 LEU A 644 GLY A 676 LEU A 799 CYH A 809 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 (-3.6A)	0.48A	4agcA-1t46A: 42.9	4agcA-1t46A: 49.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4AGD_A_B49A2000_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 11	LEU A 595 ALA A 621 LYS A 623 VAL A 654 CYH A 673 GLY A 676 LEU A 799 CYH A 809 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 (-3.6A)	0.65A	4agdA-1t46A: 33.3	4agdA-1t46A: 49.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ASD_A_BAXA1500_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 LEU A 644 GLY A 676 LEU A 783 HIS A 790 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 ( 3.8A) None STI  A   3 (-4.5A) STI  A   3 (-3.6A)	0.70A	4asdA-1t46A: 32.9	4asdA-1t46A: 49.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ASD_A_BAXA1500_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 6	VAL A 654 CYH A 673 LEU A 799 ILE A 808 CYH A 809	STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) None STI  A   3 (-4.5A)	0.32A	4asdA-1t46A: 32.9	4asdA-1t46A: 49.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 TYR A 672 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.87A	4bkjA-1t46A: 33.6	4bkjA-1t46A: 32.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.78A	4bkjB-1t46A: 33.7	4bkjB-1t46A: 32.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_B_STIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 5	LYS A 623 LEU A 647 TYR A 672 ARG A 791	STI  A   3 (-3.7A) None STI  A   3 ( 4.0A) None	1.04A	4bkjB-1t46A: 33.7	4bkjB-1t46A: 32.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 LYS A 623 GLU A 640 HIS A 790 LEU A 799 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.77A	4c8bA-1t46A: 27.3	4c8bA-1t46A: 26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	ALA A 621 LYS A 623 GLU A 640 LEU A 644 THR A 670 HIS A 790 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.46A	4c8bA-1t46A: 27.3	4c8bA-1t46A: 26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 5	VAL A 603 ILE A 653 TYR A 672 ILE A 808	STI  A   3 ( 4.6A) None STI  A   3 ( 4.0A) None	0.44A	4c8bA-1t46A: 27.3	4c8bA-1t46A: 26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 LYS A 623 GLU A 640 HIS A 790 LEU A 799 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.83A	4c8bB-1t46A: 26.8	4c8bB-1t46A: 26.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	ALA A 621 LYS A 623 GLU A 640 LEU A 644 ILE A 653 THR A 670 HIS A 790 LEU A 799 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) None STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.59A	4c8bB-1t46A: 26.8	4c8bB-1t46A: 26.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKI_A_ADNA2022_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 11	LEU A 595 GLY A 596 VAL A 603 ALA A 621 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.51A	4ckiA-1t46A: 33.1	4ckiA-1t46A: 45.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 10	LEU A 595 GLY A 596 GLY A 598 VAL A 603 ALA A 621 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.53A	4ckjA-1t46A: 33.8	4ckjA-1t46A: 45.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 GLU A 640 THR A 670 TYR A 672 LEU A 799 ASP A 810 PHE A 811	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.84A	4csvA-1t46A: 32.4	4csvA-1t46A: 38.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.53A	4csvA-1t46A: 32.4	4csvA-1t46A: 38.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.68A	4hjoA-1t46A: 25.4	4hjoA-1t46A: 31.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 11	VAL A 603 ALA A 621 LYS A 623 ASP A 677 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) None STI  A   3 (-4.4A) STI  A   3 (-3.9A)	1.16A	4iaaA-1t46A: 3.5	4iaaA-1t46A: 27.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	VAL A 603 ALA A 621 ASP A 677 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) None STI  A   3 (-4.4A)	0.79A	4l9iA-1t46A: 7.9	4l9iA-1t46A: 23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 8	VAL A 603 ALA A 621 LYS A 623 ASP A 677 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) None STI  A   3 (-4.4A)	0.90A	4l9iB-1t46A: 21.1	4l9iB-1t46A: 23.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLY A 676 ASP A 677 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 ( 3.8A) None STI  A   3 (-4.4A)	0.54A	4mkcA-1t46A: 25.6	4mkcA-1t46A: 34.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A)	0.88A	4mxoA-1t46A: 31.1	4mxoA-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.85A	4mxoB-1t46A: 24.9	4mxoB-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.77A	4mxoB-1t46A: 24.9	4mxoB-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.80A	4mxxA-1t46A: 24.7	4mxxA-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.94A	4mxxA-1t46A: 24.7	4mxxA-1t46A: 35.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.73A	4mxxB-1t46A: 25.9	4mxxB-1t46A: 35.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0S_A_ADNA500_1 (AURORA KINASE A)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 11	LEU A 595 GLY A 596 VAL A 603 ALA A 621 LYS A 623 ASN A 797 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) None STI  A   3 (-4.4A)	0.67A	4o0sA-1t46A: 24.0	4o0sA-1t46A: 25.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0U_A_ADNA501_1 (AURORA KINASE A)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 6	VAL A 603 ALA A 621 LYS A 623 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A)	0.63A	4o0uA-1t46A: 22.5	4o0uA-1t46A: 25.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0W_A_ADNA501_1 (AURORA KINASE A)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 6	LEU A 595 GLY A 596 VAL A 603 ALA A 621 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.4A)	0.45A	4o0wA-1t46A: 24.0	4o0wA-1t46A: 25.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_A_ADNA401_1 (CYCLIN-DEPENDENT KINASE 9)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 8	VAL A 603 ALA A 621 ASP A 677 ASN A 797 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) None None STI  A   3 (-4.4A)	0.54A	4ogrA-1t46A: 22.9	4ogrA-1t46A: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 7	GLY A 596 ALA A 621 CYH A 673 ASP A 677 ASN A 797 LEU A 799	None STI  A   3 (-3.5A) STI  A   3 (-4.5A) None None STI  A   3 (-4.4A)	0.67A	4ogrE-1t46A: 17.4	4ogrE-1t46A: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 9	VAL A 603 ALA A 621 CYH A 673 ASP A 677 ASN A 797 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.5A) None None STI  A   3 (-4.4A)	0.52A	4ogrI-1t46A: 17.5	4ogrI-1t46A: 24.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTI_A_MI1A1001_1 (SERINE/THREONINE-PRO TEIN KINASE N1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 GLY A 596 GLY A 601 VAL A 603 ALA A 621 VAL A 654 LEU A 799	STI  A   3 ( 3.8A) None None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 (-4.4A)	0.57A	4otiA-1t46A: 14.0	4otiA-1t46A: 24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 LYS A 623 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.77A	4otwA-1t46A: 26.4	4otwA-1t46A: 29.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QRC_A_0LIA802_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 8	LEU A 595 VAL A 603 HIS A 790 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-4.5A) STI  A   3 (-4.4A)	0.25A	4qrcA-1t46A: 35.2	4qrcA-1t46A: 48.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R7I_A_STIA1001_1 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 12	VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 CYH A 673 CYH A 788 LEU A 799 ASP A 810 PHE A 811	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 (-2.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.34A	4r7iA-1t46A: 42.4	4r7iA-1t46A: 67.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4R7I_A_STIA1001_2 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 5	LEU A 595 VAL A 654 VAL A 668 TYR A 672 ARG A 791	STI  A   3 ( 3.8A) STI  A   3 (-4.3A) STI  A   3 (-4.6A) STI  A   3 ( 4.0A) None	0.61A	4r7iA-1t46A: 42.4	4r7iA-1t46A: 67.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 THR A 670 CYH A 673	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 (-4.5A)	0.31A	4rzvB-1t46A: 22.9	4rzvB-1t46A: 30.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 GLU A 640 CYH A 788 HIS A 790 LEU A 799 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-2.8A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.79A	4tyjA-1t46A: 35.7	4tyjA-1t46A: 48.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 6	LEU A 595 VAL A 603 ILE A 653 ARG A 791 ILE A 808	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) None None None	0.60A	4tyjA-1t46A: 35.7	4tyjA-1t46A: 48.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	10 / 10	LEU A 595 VAL A 603 GLU A 640 LEU A 647 ILE A 653 VAL A 654 VAL A 668 TYR A 672 ARG A 791 ILE A 808	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.6A) None None STI  A   3 (-4.3A) STI  A   3 (-4.6A) STI  A   3 ( 4.0A) None None	0.37A	4u0iA-1t46A: 35.8	4u0iA-1t46A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	12 / 12	ALA A 621 LYS A 623 LEU A 644 THR A 670 CYH A 673 GLY A 676 CYH A 788 HIS A 790 LEU A 799 CYH A 809 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-2.8A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-4.5A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.35A	4u0iA-1t46A: 35.8	4u0iA-1t46A: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_B_RXTB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 9	LEU A 595 VAL A 603 ALA A 621 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.56A	4u5jB-1t46A: 31.3	4u5jB-1t46A: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_B_RXTB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 9	LEU A 595 VAL A 603 ALA A 621 TYR A 672 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.74A	4u5jB-1t46A: 31.3	4u5jB-1t46A: 35.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4UXQ_A_0LIA1752_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 ALA A 621 GLU A 640 CYH A 788 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-2.8A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.73A	4uxqA-1t46A: 29.7	4uxqA-1t46A: 49.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4UXQ_A_0LIA1752_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 ALA A 621 LEU A 783 CYH A 788 HIS A 790 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) None STI  A   3 (-2.8A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.52A	4uxqA-1t46A: 29.7	4uxqA-1t46A: 49.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	ALA A 621 GLU A 640 HIS A 790 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.82A	4v01A-1t46A: 26.9	4v01A-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	ALA A 621 GLU A 640 LEU A 783 HIS A 790 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.69A	4v01A-1t46A: 26.9	4v01A-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 9	LEU A 595 VAL A 603 LYS A 623 TYR A 672 ARG A 791 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 ( 4.0A) None STI  A   3 (-4.4A)	1.07A	4v01A-1t46A: 26.9	4v01A-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 9	LEU A 595 VAL A 603 TYR A 672 CYH A 788 ARG A 791 LEU A 799 ILE A 808	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 ( 4.0A) STI  A   3 (-2.8A) None STI  A   3 (-4.4A) None	0.86A	4v01A-1t46A: 26.9	4v01A-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 LEU A 783 CYH A 788 HIS A 790 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-2.8A) STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.60A	4v01B-1t46A: 26.9	4v01B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 9	LEU A 595 VAL A 603 LYS A 623 TYR A 672 ARG A 791 LEU A 799 ILE A 808	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 ( 4.0A) None STI  A   3 (-4.4A) None	0.53A	4v01B-1t46A: 26.9	4v01B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 9	LEU A 595 VAL A 603 LYS A 623 TYR A 672 LEU A 799 ILE A 653	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) None	1.05A	4v01B-1t46A: 26.9	4v01B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 LEU A 783 CYH A 788 HIS A 790 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-2.8A) STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.68A	4v04A-1t46A: 34.3	4v04A-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 10	LEU A 595 VAL A 603 LYS A 623 TYR A 672 ARG A 791 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 ( 4.0A) None STI  A   3 (-4.4A)	1.09A	4v04B-1t46A: 28.7	4v04B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 10	LEU A 595 VAL A 603 LYS A 623 TYR A 672 LEU A 799 ILE A 653	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A) None	0.98A	4v04B-1t46A: 28.7	4v04B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 10	LEU A 595 VAL A 603 TYR A 672 ARG A 791 LEU A 799 ILE A 808	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 ( 4.0A) None STI  A   3 (-4.4A) None	0.83A	4v04B-1t46A: 28.7	4v04B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	ALA A 621 GLU A 640 HIS A 790 ASP A 810 PHE A 811	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 (-3.9A) STI  A   3 (-3.6A)	0.80A	4v04B-1t46A: 28.7	4v04B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 LEU A 783 CYH A 788 HIS A 790 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) None STI  A   3 (-2.8A) STI  A   3 (-4.5A) STI  A   3 (-3.9A)	0.71A	4v04B-1t46A: 28.7	4v04B-1t46A: 48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WKQ_A_IREA1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.69A	4wkqA-1t46A: 30.6	4wkqA-1t46A: 31.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XEY_A_1N1A601_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 VAL A 654 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.80A	4xeyA-1t46A: 32.9	4xeyA-1t46A: 29.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_A_1N1A601_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.70A	4xliA-1t46A: 32.5	4xliA-1t46A: 36.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_B_1N1B600_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 ALA A 621 GLU A 640 VAL A 654 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.74A	4xliB-1t46A: 32.1	4xliB-1t46A: 36.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_B_1N1B600_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.65A	4xliB-1t46A: 32.1	4xliB-1t46A: 36.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 THR A 670 CYH A 673	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 (-4.5A)	0.25A	4xv2A-1t46A: 21.9	4xv2A-1t46A: 30.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ZAU_A_YY3A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 8	LEU A 595 GLY A 596 VAL A 603 ALA A 621 GLY A 676	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 ( 3.8A)	0.49A	4zauA-1t46A: 30.6	4zauA-1t46A: 31.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AJQ_A_DB8A800_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 ALA A 621 LYS A 623 CYH A 673 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.86A	5ajqA-1t46A: 22.5	5ajqA-1t46A: 28.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AJQ_B_DB8B800_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 10	ALA A 621 CYH A 673 GLY A 676 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.24A	5ajqB-1t46A: 22.1	5ajqB-1t46A: 28.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	9 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.47A	5bvwA-1t46A: 28.2	5bvwA-1t46A: 32.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 LEU A 644 THR A 670	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A) STI  A   3 (-3.2A)	0.69A	5cswA-1t46A: 22.1	5cswA-1t46A: 30.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 THR A 670 CYH A 673	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 (-4.5A)	0.26A	5cswA-1t46A: 22.1	5cswA-1t46A: 30.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 LEU A 644 THR A 670	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-4.4A) STI  A   3 (-3.2A)	0.77A	5cswB-1t46A: 26.7	5cswB-1t46A: 30.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	VAL A 603 ALA A 621 LYS A 623 THR A 670 CYH A 673	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 (-4.5A)	0.34A	5cswB-1t46A: 26.7	5cswB-1t46A: 30.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_A_1N1A501_1 (PROTEIN-TYROSINE KINASE 6)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 VAL A 603 ALA A 621 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.70A	5h2uA-1t46A: 25.7	5h2uA-1t46A: 37.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 VAL A 603 ALA A 621 THR A 670 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.73A	5h2uB-1t46A: 25.9	5h2uB-1t46A: 37.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HES_B_032B401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	VAL A 603 ALA A 621 LYS A 623 THR A 670 TYR A 672 CYH A 809	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 (-4.5A)	0.66A	5hesB-1t46A: 24.7	5hesB-1t46A: 28.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HI2_A_BAXA801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	ALA A 621 LYS A 623 GLU A 640 LEU A 644 THR A 670 CYH A 673 LEU A 783 HIS A 790	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.4A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) None STI  A   3 (-4.5A)	0.64A	5hi2A-1t46A: 18.8	5hi2A-1t46A: 30.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HI2_A_BAXA801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 8	VAL A 603 VAL A 643 ILE A 653 ILE A 808 ASP A 810	STI  A   3 ( 4.6A) None None None STI  A   3 (-3.9A)	0.71A	5hi2A-1t46A: 18.8	5hi2A-1t46A: 30.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HIE_C_P06C801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 12	GLY A 596 VAL A 603 ALA A 621 LYS A 623 THR A 670	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.2A)	0.40A	5hieC-1t46A: 23.3	5hieC-1t46A: 30.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5I9X_A_DB8A1001_1 (EPHRIN TYPE-A RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.94A	5i9xA-1t46A: 27.9	5i9xA-1t46A: 33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5I9Y_A_1N1A1001_1 (EPHRIN TYPE-A RECEPTOR 2)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.71A	5i9yA-1t46A: 33.5	5i9yA-1t46A: 33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 7	GLY A 596 GLY A 598 GLY A 601 VAL A 603	None None None STI  A   3 ( 4.6A)	0.34A	5izjB-1t46A: 15.7	5izjB-1t46A: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	GLY A 596 VAL A 603 ALA A 621 VAL A 654 ASP A 677 LEU A 799	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) None STI  A   3 (-4.4A)	0.53A	5l2iA-1t46A: 6.6	5l2iA-1t46A: 26.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	GLY A 596 VAL A 603 ALA A 621 VAL A 654 ASP A 677 LEU A 799	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) None STI  A   3 (-4.4A)	0.89A	5l2tA-1t46A: 22.1	5l2tA-1t46A: 26.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LVN_A_ADNA402_1 (3-PHOSPHOINOSITIDE-D EPENDENT PROTEIN KINASE 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 11	LEU A 595 GLY A 596 VAL A 603 ALA A 621 VAL A 654 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.70A	5lvnA-1t46A: 22.9	5lvnA-1t46A: 25.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_1 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	GLY A 596 VAL A 603 ALA A 621 LYS A 623 GLU A 640 TYR A 672 GLY A 676	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A)	0.81A	5mafA-1t46A: 23.0	5mafA-1t46A: 14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_1 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 10	LEU A 595 VAL A 603 LYS A 623 GLU A 640 GLY A 676 PHE A 811	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 ( 3.8A) STI  A   3 (-3.6A)	1.23A	5mo4A-1t46A: 9.0	5mo4A-1t46A: 24.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 VAL A 643 VAL A 654 HIS A 790 LEU A 799 ASP A 810	STI  A   3 (-3.5A) None STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.38A	5mo4A-1t46A: 9.0	5mo4A-1t46A: 24.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N3H_A_NCAA401_0 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 10	LEU A 595 VAL A 603 ALA A 621 VAL A 654 TYR A 672 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 ( 4.0A) STI  A   3 (-4.4A)	0.48A	5n3hA-1t46A: 21.9	5n3hA-1t46A: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OWR_A_1N1A401_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 8	ALA A 621 GLU A 640 CYH A 673 LEU A 799	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 (-4.4A)	0.51A	5owrA-1t46A: 20.5	5owrA-1t46A: 29.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5P9I_A_1E8A701_1 (TYROSINE-PROTEIN KINASE BTK)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	GLY A 596 VAL A 603 ALA A 621 THR A 670 GLY A 676 ASN A 680 LEU A 799	None STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A) None STI  A   3 (-4.4A)	1.18A	5p9iA-1t46A: 27.1	5p9iA-1t46A: 34.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TE0_A_XINA401_2 (AP2-ASSOCIATED PROTEIN KINASE 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	4 / 5	LEU A 595 VAL A 603 CYH A 673 CYH A 809	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-4.5A) STI  A   3 (-4.5A)	0.52A	5te0A-1t46A: 18.0	5te0A-1t46A: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	ALA A 621 GLU A 640 TYR A 672 CYH A 673 GLY A 676 ASP A 810	STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 ( 4.0A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-3.9A)	0.96A	5vc3A-1t46A: 18.2	5vc3A-1t46A: 24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	GLY A 596 ALA A 621 TYR A 672 CYH A 673 GLY A 676 ASP A 677	None STI  A   3 (-3.5A) STI  A   3 ( 4.0A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) None	1.07A	5vc3A-1t46A: 18.2	5vc3A-1t46A: 24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_1 (WEE1-LIKE PROTEIN KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	GLY A 596 ALA A 621 TYR A 672 CYH A 673 GLY A 676 ASP A 810	None STI  A   3 (-3.5A) STI  A   3 ( 4.0A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-3.9A)	0.93A	5vc3A-1t46A: 18.2	5vc3A-1t46A: 24.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCV_A_1N1A404_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 ALA A 621 LYS A 623 GLU A 640 THR A 670 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 3.8A)	0.97A	5vcvA-1t46A: 22.6	5vcvA-1t46A: 23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 CYH A 673	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.5A)	0.66A	5vcyA-1t46A: 22.4	5vcyA-1t46A: 23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W5V_A_ANWA701_0 (SERINE/THREONINE-PRO TEIN KINASE TBK1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	5 / 9	LEU A 595 ALA A 621 VAL A 654 CYH A 673 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-4.3A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A)	0.71A	5w5vA-1t46A: 10.4	5w5vA-1t46A: 19.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 CYH A 673 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.67A	5y7zA-1t46A: 23.1	5y7zA-1t46A: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 CYH A 673 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.67A	5y7zA-1t46A: 23.1	5y7zA-1t46A: 26.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y7Z_B_IREB401_0 (CYCLIN-G-ASSOCIATED KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	LEU A 595 ALA A 621 GLU A 640 CYH A 673 GLY A 676 LEU A 799 CYH A 809	STI  A   3 ( 3.8A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A) STI  A   3 (-4.5A)	0.58A	5y7zB-1t46A: 23.2	5y7zB-1t46A: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y80_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 THR A 670 CYH A 673 GLY A 676 LEU A 799	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.50A	5y80A-1t46A: 22.6	5y80A-1t46A: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y80_A_IREA401_0 (CYCLIN-G-ASSOCIATED KINASE)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 CYH A 673 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 (-4.5A) STI  A   3 ( 3.8A)	0.59A	5y80A-1t46A: 22.6	5y80A-1t46A: 12.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 TYR A 672 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A)	0.45A	5zv2A-1t46A: 28.7	5zv2A-1t46A: 18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_B_LEVB801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	6 / 12	LEU A 595 VAL A 603 ALA A 621 LYS A 623 GLU A 640 GLY A 676	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 ( 3.8A)	0.48A	5zv2B-1t46A: 28.8	5zv2B-1t46A: 18.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BSD_A_1N1A901_0 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	VAL A 603 ALA A 621 LYS A 623 GLU A 640 THR A 670 TYR A 672 GLY A 676 LEU A 799	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.7A) STI  A   3 (-3.6A) STI  A   3 (-3.2A) STI  A   3 ( 4.0A) STI  A   3 ( 3.8A) STI  A   3 (-4.4A)	0.52A	6bsdA-1t46A: 27.8	6bsdA-1t46A: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_0 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.54A	6hd4A-1t46A: 33.7	6hd4A-1t46A: 14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.55A	6hd4B-1t46A: 28.2	6hd4B-1t46A: 14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_A_STIA603_0 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	7 / 12	VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.55A	6hd6A-1t46A: 34.0	6hd6A-1t46A: 14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_B_STIB601_0 (TYROSINE-PROTEIN KINASE ABL1)	1t46	HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG (Homo sapiens)	8 / 12	LEU A 595 VAL A 603 ALA A 621 GLU A 640 VAL A 654 THR A 670 LEU A 799 ASP A 810	STI  A   3 ( 3.8A) STI  A   3 ( 4.6A) STI  A   3 (-3.5A) STI  A   3 (-3.6A) STI  A   3 (-4.3A) STI  A   3 (-3.2A) STI  A   3 (-4.4A) STI  A   3 (-3.9A)	0.63A	6hd6B-1t46A: 33.7	6hd6B-1t46A: 14.24